MOHINDER S PEGANY M.D. NPI 1992798987

NPI Details

Mohinder S Pegany, M.D. is an internal medicine in Cedar Park, TX with 34 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Mohinder S Pegany, M.D. NPI is 1992798987. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Graduation Year:1992

The provider's business location address is:

801 E WHITESTONE BLVD
BLDG C
CEDAR PARK, TX
ZIP 78613-028
Phone: (512) 259-3467
Fax: (512) 406-7303

The NPI 1992798987 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hemoglobin a1c level (HCPCS:83036)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Urine microalbumin (protein) level (HCPCS:82043)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Bacterial colony count, urine (HCPCS:87086)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Hepatitis c antibody measurement (HCPCS:86803)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Hepatitis c antibody screening, for individual at high risk and other covered indication(s) (HCPCS:G0472)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Automated urinalysis test (HCPCS:81003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• X-ray of chest, 2 views (HCPCS:71046)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Ferritin (blood protein) level (HCPCS:82728)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) (HCPCS:80051)
• Special stain for parasites (HCPCS:87209)
• Smear for parasites (HCPCS:87177)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• X-ray of paranasal sinus, minimum of 3 views (HCPCS:70220)
• Vitamin d-3 level (HCPCS:82306)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Coronavirus vaccine 14 (HCPCS:91313)

The enumeration date for this NPI number is 8/25/2005 and was last updated on 5/14/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.